Cybin (HELP) Treasury Shares (2021 - 2022)
Cybin (HELP) posted quarterly Treasury Shares of $12.5 million for Q1 2022, down 57.81% year-on-year from $29.7 million in Q1 2021, and down 57.81% on a QoQ basis from $29.7 million in Q1 2021.
Cybin (HELP) Treasury Shares (2021 - 2022) Analysis & Trends
Cybin (HELP) has reported Treasury Shares for 2 consecutive years, with $12.5 million the latest figure, recorded in Q1 2022.
- Quarterly Treasury Shares fell 57.81% year-over-year to $12.5 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $12.5 million (down 57.81% YoY) and the FY2022 annual result came in at $12.5 million, down 55.98% from the prior year.
- Treasury Shares eased to $12.5 million in Q1 2022 per HELP's latest filing, from $29.7 million in the prior quarter.
- Over the last five years, Treasury Shares for HELP reached as high as $29.7 million in Q1 2021 and fell as low as $12.5 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 12.55 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Mar 31, 2021 | 29.74 Mn |
| Mar 31, 2021 | 29.74 Mn |